Cardiopulmonary bypass and the adaptive immune system: Perspectives on T cell function

Perfusion

Volumn 11, Issue 3, 1996, Pages 281-290

  Hornick, Philip ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPULMONARY BYPASS; CONFERENCE PAPER; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE SYSTEM; NATURAL KILLER CELL; NEUTROPHIL; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; T LYMPHOCYTE;

EID: 0029797580     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765919601100315     Document Type: Conference Paper

References (58)

1. Lenfant C, Roth C. Advances in cardiology and escalating costs to the patient: a view from government. Circulation 1985; 71: 424-28.
2. Kirklin J, McGriffin D. Early complications following cardiac surgery. Cardiovasc Clin 1987; 17: 321-43.
3. Miedzinsky L, Karen G. Serious infectious complications of open heart surgery. Can J Surg 1987; 30: 103-107.
4. Westaby S. Complement and the damaging effects of cardiopulmonary bypass. Thorax 1983; 38: 321-25.
5. Kirklin JW, Donald DE, Harshbarger HG et al. Studies in extracorporeal circulation 1. Applicability of Gibbon-type pump-oxygenator to human intracardiac surgery: 40 cases. Ann Surg 1956; 144: 2-8.
6. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effect of cardiac surgery. J Thorac Cardiovasc Surg 1983; 86: 845-57.
7. Van Velzen-Blad H, Dijkstra YJ, Heijnen CJ et al. Cardiopulmonary bypass and host defence functions in human beings, lymphocyte function. Ann Thorac Surg 1985; 39: 212-17.
8. Utley JR. Renal effects of cardiopulmonary bypass. In: Utley JR ed. Pathophysiology and techniques of cardiopulmonary bypass. Baltimore: Williams & Wilkins, 1982: 40-54.
9. Utley JR. Pathophysiology of cardiopulmonary bypass: A current review. Aust J Cardiac Thorac Surg 1992; 1(2): 46-52.
10. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304: 497-503.
11. Hammerschmidt D, Strcek D, Bowers T et al. Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1981; 81: 370-77.
12. Westaby S. Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit. Intensive Care Med 1987; 13: 89-95.
13. Cochran A, Spilg W, Mackies R et al. Post-operative depression of tumour-directed cell-mediated immunity in patients with malignant disease. Br Med J 1972; 4: 67-70.
14. Cullen B, van Belle G. Lymphocyte transformation and changes in leukocyte count: effects of anesthesia and operation. Anesthesiology 1975; 43: 563-67.
15. Han T. Postoperative immunosuppression in patients with breast cancer. Lancet 1974; i: 742-46.
16. Hofmann J, Helm L, Boulanger W, DeCosse J. The effect of surgery on cellular immunity. Wis Med J 1973; 72: 249-55.
17. Jubert A, Lee E, Hersh E et al. Effects of surgery, anesthesia and intraoperative blood loss on immunocompetence. J Surg Res 1973; 15: 399-402.
18. Lee YTN. Effect of anesthesia and surgery on immunity. J Surg Oncol 1977; 9: 425-29.
19. Park S, Brady J, Wallace H, Blakemore W. Immunosuppressive effect of surgery. Lancet 1971; i: 53-57.
20. Riddle P, Berenbaum M. Postoperative depression of lymphocyte response to phytohaemagglutinin. Lancet 1967; ii: 746-49.
21. Roth J, Golub S, Grimm E et al. Effect of surgery on in vitro lymphocyte function. Surg Forum 1974; 25: 102-106.
22. Slade M, Simmons R, Yunis E et al. Immunodepression after major surgery in normal patients. Surgery 1975; 78: 363-67.
23. Ulicny K, Hiratzka L. The risk factors of median sternotomy infection: a current review. J Card Surg 1991; 6: 338-51.
24. Loop F, Lytle B, Cosgrove D et al. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity and cost of care. Ann Thorac Surg 1990; 49: 179-87.
25. Bucknall T. Factors affecting healing. In: Bucknall T, Ellis H eds. Wound healing for surgeons. London: Baillière Tindall, 1987: 42ff.
26. Serry C, Bleck P, Javid H et al. Sternal wound complications: management and results. J Thorac Cardiovasc Surg 1980; 80: 861-67.
27. Eskola J, Salo M, Viljanem K, Ruuskanenn O. Impaired B lymphocyte function during open heart surgery. Br J Anaesth 1984; 56: 333-37.
28. Salo M, Seppi E, Lassila O et al. Effect of anesthesia and open-heart surgery on lymphocyte responses to phytohaemagglutinin and concavalin A. Acta Anaesthesiol Scand 1978; 22: 471-75.
29. Goris J, Boeckhorst T, Nuytinck J et al. Multiple organ failure generalized autodestructive inflammation. Arch Surg 1985; 120: 1109-15.
30. Markewitz A, Faist E, Lang S et al. Successful restoration of cell mediated immune response after cardiopulmonary bypass by immunomodulation. J Thorac Cardiovasc Surg 1993; 105: 15-24.
31. Alexander J. The role of host defence functions in surgical infections. Surg Clin North Am 1980; 60: 107-11.
32. Dankert J. The use of a mobile cross-flow unit in open-heart surgery: a bacteriological evaluation. Antonie Van Leeuwenhoek 1978; 44: 247-53.
33. Markewitz A, Faist E, Niesel S et al. Changes in lymphocyte subsets and mitogen responsiveness following open heart surgery and possible therapeutic approaches. Thorac Cardiovasc Surg 1992; 40: 14-18.
34. Gierhake F, Johannsen P, Stocker R et al. Immunosuppressive Wirkungen bei Operationen und Möglichkeiten ihrer Begrenzung. Immun Infekt 1975; 3: 116-19.
35. Roth J, Golub S, Cuckingnan R et al. Cell-mediated immunity is depressed following cardiopulmonary bypass. Ann Thorac Surg 1981; 31: 350-56.
36. Parker FB, Marvast MA, Bove EL. Neurologic complications following coronary artery bypass: the role of atherosclerotic emboli. Thorac Cardiovasc Surg 1985; 33: 207-209.
37. van Velzen-Blad H, Dijkstra Y, Schurink G et al. Cardiopulmonary bypass and host defence functions in human beings: Serum levels and the role of immunoglobulins and complement in phagocytosis. Ann Thorac Surg 1985; 39: 207-13.
38. Mayer J, McCullough J, Weiblen B et al. Effects of cardiopulmonary bypass on neutrophil chemotaxis. Surg Forum 1976; 27: 285-89.
39. Boonstra P, Vermeulen F, Leusink J et al. Hematological advantage of a membrane oxygenator over a bubble oxygenator in long perfusion. Ann Thorac Surg 1986; 41: 297-300.
40. Bubenink O, Meakins J. Neutrophil chemotaxis in surgical patients: effect of cardiopulmonary bypass. Surg Forum 1976; 27: 267-69.
41. Burrows F, Steele R, Marmer D et al. Influence of operations with cardiopulmonary bypass on polymorphonuclear leukocyte function in infants. J Thorac Cardiovasc Surg 1987; 93: 253-60.
42. van Oeveren W, Dankert J, Wildevuur CRH. Bubble oxygenation and cardiotomy suction impair the host defence during cardiopulmonary bypass, a study in dogs. Ann Thorac Surg 1987; 44: 523-28.
43. De Palma L, Yu M, McIntosh C et al. Changes in lymphocyte subpopulations as a result of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991; 101: 240-44.
44. Kress HG, Gehrsitz P, Elert O. Predictive value of skin test in neutrophil migration and C-reactive protein for post-operative infections in cardiopulmonary bypass patients. Acta Anaesthesiol Scand 1987; 31: 397-404.
45. Larmi TKI, Karkola P. Plasma protein electrophoresis during a three hour cardiopulmonary bypass in dogs. Scand J Thorac Cardiovasc Surg 1974; 8: 152-57.
46. Lee WHJ, Krumhaar D, Fonkalsrud EW et al. Denaturation of plasma proteins as a cause of morbidity and death after intracardiac operations. Surgery 1961; 50: 29-33.
47. Ryhaenen P, Huttunen K, Llonen J. Natural killer cell activity after open heart surgery. Acta Anaesthesiol Scand 1984; 28: 490-92.
48. Nguyen D, Mulder D, Shennib H. Effect of cardiopulmonary bypass on circulating lymphocyte function. Ann Thorac Surg 1992; 53: 611-16.
49. Subramanian V, Lowman J, Gans H. Effect of extracorporeal circulation on recticuloendothelial function. Impairment and its relationship to blood trauma. Arch Surg 1968; 97: 330-34.
50. Brody H, Pickering N, Fink G et al. Altered lymphocyte subsets during cardiopulmonary bypass. Am J Clin Pathol 1987; 87: 626-28.
51. Pollock R, Ames R, Rubio P et al. Protracted severe immune deregulation induced by cardiopulmonary bypass: a predisposing etiologic factor in blood transfusion-related AIDS? J Clin Lab Immunol 1987; 22: 1-5.
52. Ide H, Kackiuchi T, Furata N et al. The effect of cardiopulmonary bypass on T cells and their subpopulations. Ann Thorac Surg 1987; 44: 277-82.
53. Ryhaenen P, Herna E, Hollmen A et al. Changes in peripheral blood leucocyte counts, lymphocyte subpopulations and in vitro transformation after heart valve replacement. J Thorac Cardiovasc Surg 1979; 77: 259-66.
54. Hisatomi K, Isomura T, Kawara T et al. Changes in lymphocyte subsets, mitogen responsiveness, and interleukin 2 production after cardiac operations. J Thorac Cardiovasc Surg 1989; 98: 580-91.
55. Keller S, Weiss J, Scheifer S et al. Stress-induced suppression of immunity in adrenalectomized rats. Science 1983; 221: 1301-1303.
56. Yu D, Clements P, Paulus H et al. Human lymphocyte subpopulations: effect of corticosteroids. J Clin Invest 1974; 53: 565-68.
57. Tajima K, Yamamoto F, Kawazoe K et al. Cardiopulmonary bypass and cellular immunity: changes in lymphocyte subsets and natural killer cell activity. Ann Thorac Surg 1992; 55: 625-30.
58. Sharrock CEM, Kaminski E, Man S. Limiting dilution analysis of human T cells: a useful clinical tool. Immunol Today 1990; 11: 281-86.